<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Hematol Oncol Stem Cell Res</journal-id><journal-id journal-id-type="iso-abbrev">Int J Hematol Oncol Stem Cell Res</journal-id><journal-id journal-id-type="publisher-id">IJHOSCR</journal-id><journal-title-group><journal-title>International Journal of Hematology-Oncology and Stem Cell Research</journal-title></journal-title-group><issn pub-type="ppub">2008-3009</issn><issn pub-type="epub">2008-2207</issn><publisher><publisher-name>Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center</publisher-name><publisher-loc>Tehran, Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4969557</article-id><article-id pub-id-type="publisher-id">IJHOSCR-10-130</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Association between Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphisms and Susceptibility to Childhood Acute Lymphoblastic Leukemia in an Iranian Population</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bahari</surname><given-names>Gholamreza</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hashemi</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Naderi</surname><given-names>Majid</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Taheri</surname><given-names>Mohsen</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran</aff><aff id="aff2"><label>2</label>Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran</aff><aff id="aff3"><label>3</label>Genetics of Non-Communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran</aff><author-notes><corresp id="cor">Corresponding Author: Mohammad Hashemi, PhD. Professor of Clinical Biochemistry, Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran. Tel: +985433295791. Fax: +985433295796<email>hashemim@zaums.ac.ir</email></corresp></author-notes><pub-date pub-type="ppub"><day>1</day><month>7</month><year>2016</year></pub-date><volume>10</volume><issue>3</issue><fpage>130</fpage><lpage>137</lpage><history><date date-type="received"><day>22</day><month>7</month><year>2015</year></date><date date-type="accepted"><day>15</day><month>9</month><year>2015</year></date></history><permissions><copyright-statement>Copyright : &#169; International Journal of Hematology-Oncology and Stem Cell Research &amp; Tehran University of Medical Sciences</copyright-statement><license><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>
<bold>Background:</bold> The present study was aimed to examine the possible association between methylene tetrahydrofolate reductase (MTHFR) gene polymorphisms and childhood acute lymphoblastic leukemia (ALL) in a sample of Iranian population.</p><p>
<bold>Subjects and Methods:</bold> A total of 220 subjects including 100 children diagnosed with ALL and 120 healthy children participated in the case-control study. The single nucleotide polymorphisms (SNPs) of MTHFR were determined by ARMS-PCR or PCR-RFLP method.</p><p>
<bold>Results:</bold> Our investigation revealed that rs13306561 both TC and TC + CC genotypes decreased the risk of ALL compared to TT genotype (OR=0.32, 95%CI=0.15-0.68, p=0.002 and OR=0.35, 95%CI=0.17-0.70, p=0.003, respectively). In addition, the rs13306561 C allele decreased the risk of ALL in comparison with T allele (OR=0.42, 95% CI=0.22-0.78, P=0.005). MTHFR rs1801131 (A1298C) polymorphism showed that the AC heterozygous genotype decreased the risk of ALL in comparison with AA homozygous genotype (OR=0.43, 95%CI=0.21-0.90, p=0.037). Neither the overall Chi-square comparison of cases and control subjects (&#120594;2=5.54, p=0.063) nor the logistic regression analysis showed significant association between C677T polymorphism and ALL (OR=1.25, 95% CI=0.69-2.23, p=0.552; CT vs. CC).</p><p>
<bold>Conclusion:</bold> The current investigation findings showed that MTHFR rs1801131 and rs13306561 polymorphisms decreased the risk of ALL in the population which has been studied. Further studies with larger sample sizes and different ethnicities are required to validate our findings.</p></abstract><kwd-group><title>Key Words</title><kwd>MTHFR</kwd><kwd>Polymorphism</kwd><kwd>Acute lymphocytic leukemia</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p> Pediatric cancer is currently the second most common cause of cancer death in children who live in developed countries.<xref rid="B1" ref-type="bibr">&#160;&#160;&#160;1&#160;</xref> Acute lymphoblastic leukemia (ALL), the most common cancer of childhood, accounts for approximately 26.8% of all pediatric cancers among children less than 15 years old.<xref rid="B2" ref-type="bibr">&#160;&#160;&#160;2&#160;</xref> Though the etiology of ALL is mainly unknown, it is recognized that genetic variation plays a critical role in disease development.<sup><xref rid="B3" ref-type="bibr">3</xref></sup><sup>,</sup><sup><xref rid="B4" ref-type="bibr">4</xref></sup> The peak rate of childhood ALL happens at age 2 to 5 years, implying that ALL may initiate in utero or during the infant period.<sup><xref rid="B2" ref-type="bibr">&#160;&#160;&#160;2&#160;</xref></sup> The MTHFR gene is located on short arm of chromosome 1 (1p36.3).<sup><xref rid="B5" ref-type="bibr">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5&#160;</xref></sup> MTHFR protein is a key enzyme in folate metabolism, which catalyzes the irreversible conversion of 5, 10-methylenetetrahydrofolate (5, 10-MTHF) to 5-Methyl THF. 5-Methyl THF is the main circulatory form of folate and provides methyl group for homocysteine methylation and conversion to methionine. It is also involved in formation of S-adenosylmethionine (SAM), the universal donor of one carbon unit for the methylation of different substrates.<sup><xref rid="B6" ref-type="bibr">6</xref></sup><sup>-</sup><sup><xref rid="B8" ref-type="bibr">8</xref></sup> Two common polymorphisms in MTHFR gene have been described: First, C to T transition at nucleotide 677 (C677T, rs1801133), which causes the substitution alanine with valine at codon 222 and decreases in the enzymatic activity and subsequently increases the level of homocysteine and altered distribution of folate.<sup><xref rid="B9" ref-type="bibr">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;9&#160;</xref></sup> Second, A to C transition at position 1298 (A1298C, rs1801131), which results in the substitution of glutamate to alanine at codon position 429 and also leads to reduced MTHFR activity.<sup><xref rid="B10" ref-type="bibr">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;10&#160;</xref></sup></p><p>Several genetic association studies have evaluated the associations between ALL and MTHFR gene polymorphisms in various populations and produced contradictory or inconclusive results.<sup><xref rid="B11" ref-type="bibr">11</xref></sup><sup>-</sup><sup><xref rid="B14" ref-type="bibr">14</xref></sup> The present study aimed to find out the possible association among rs1801131 (A1298C), rs1801133 (C677T) and rs13306561 polymorphisms in the MTHFR gene and ALL risk in a sample of the Iranian population.</p></sec><sec sec-type="subjects"><title>SUBJECTS AND METHODS</title><p>
<bold>Patients </bold>
</p><p>This case-control study has been done in children diagnosed with ALL (n=100) and control individuals (n=120), who were matched for age and sex in southeast of Iran (Zahedan). The study design and the enrolment procedure have been described previously.<sup><xref rid="B15" ref-type="bibr">15</xref></sup><sup>-</sup><sup><xref rid="B18" ref-type="bibr">18</xref></sup> Local ethics committee of Zahedan University of Medical Sciences was approved the project and informed consent was obtained from parents of cases and controls (Ethical code: 6858). DNA was extracted from peripheral whole blood using salting-out method.<sup><xref rid="B19" ref-type="bibr">19</xref></sup></p><p>
<bold>Genotyping</bold>
</p><p>Genotyping of MTHFR rs1801133 (C677T, Ala222Val) and rs13306561 gene polymorphisms was done by PCR-RFLP method. For rs1801133 variant, the forward and reverse primers were 5&#8242;-ACTCTCTCTGCCCAGTCCCTGTG-3&#8242; and 5&#8242;-AAGAACTCAGCGAACTCAGCACT-3&#8242;, respectively.</p><p>In each 0.20 ml PCR reaction tube, 1 &#181;l of genomic DNA (~100 ng/ml), 1 &#181;l of each primer, 10 &#181;l of 2X Prime Taq Premix (Genet Bio, Korea) and 7 &#181;l ddH<sub>2</sub>O were added. The PCR conditions were set as follows: 95&#730;C for 5 min, 30 cycles of 95&#730;C for 30s, 64&#730;C for 30s and 72 &#730;C for 30s and a final extension step of 72 &#730;C for 10 min. Then, 10 &#181;l of PCR product is digested with HinfI restriction enzyme. The T allele was digested and produced 222-bp and 167-bp fragments, while the C allele was undigested and produced 389-bp product.</p><p>For MTHFR rs13306561 polymorphism, a set of forward and reverse primer pairs was 5&#8242;-GGCCGAGCGTTCTGAGTC-3&#8242; and 5&#8242;-CACTAATCCCGCGAAGGGTGCTCA-3&#8242;, respectively. The PCR cycling conditions were the initial denaturation step at 95 &#176;C for 5 min, followed by 30 cycles of 95 &#176;C for 30s, 64 &#176;C for 30s, and 72 &#176;C for 30s with a final extension of 72 &#176;C for 10 min. Ten microliters of the PCR product were digested by HpyF3I restriction enzyme. The C allele was digested and produced 162-bp and 23-bp, while the T allele was undigested (185-bp).</p><p>Genotyping of MTHFR rs1801131 (A1298C) polymorphism was done using allele specific polymerase chain reaction (AS-PCR). The primer sequences were as follow: generic primers, 5&#8242;-AGACCTTCCTTGCAAATACAT-3&#8242;; A allele, 5&#8242;-GAAGACTTCAAAGACACTCT-3&#8242;; C allele, and 5&#8242;-GAAGACTTCAAAGACACTCG-3&#8242;.</p><p>The beta-2 microglobulin (B2MF: 5&#8242;-TGTAAACACTTGGTGCCTGATATAGCTTGA-3&#8242;, B2MR: 5&#8242;-CATCAGTATCTCAGCAGGTGCCACTAATCT-3&#8242;) was used as internal control.</p><p>The PCR cycling conditions were 95&#730;C for 5 min, 33 cycles of 95&#730;C for 30s, 55&#730;C for 20s, and 72&#730;C for 30s, followed by a final extension step for 10 min at 72&#730;C. The products size were 317-bp for either of the A or C alleles and 574-bp for the internal control.</p><p>
<bold>Statistical analysis</bold>
</p><p>Statistical analysis was done using statistical package SPSS 20 software. Data were analyzed by independent sample t-test and &#967;2 test. The association between MTHFR gene polymorphisms and ALL was estimated by computing the odds ratio (OR) and 95% confidence intervals (95%CI) from logistic regression analyses. Haplotype analysis was performed using SNPStats software.<sup><xref rid="B20" ref-type="bibr">20</xref></sup> A p-value less than 0.05 were considered statistically significant.</p></sec><sec sec-type="results"><title>Results</title><p> The study group involved 100 ALL patients (58 males, 42 females; age: 6.2 &#177; 3.8 years) and 120 healthy children (56 males, 64 females; age: 5.8 &#177; 2.2 years). No significant difference was found between the groups concerning sex and age (p=0.105 and 0.303, respectively).</p><p>The genotype and allelic frequencies of MTHFR gene polymorphisms in cases and controls are presented in <xref ref-type="table" rid="T1">Table 1</xref>. The results for rs1801131 (A1298C) variant showed that AC heterozygous genotype decreased the risk of ALL in comparison with AA homozygous genotype (OR=0.43, 95%CI=0.21-0.90, p=0.037). The minor allele frequency (C allele) was not associated with ALL (OR=1.36, 95%CI=0.93-1.98, p=0.12). Neither the overall Chi-square comparison of cases and control subjects (&#120594;2=5.54, p=0.063) nor the logistic regression analysis indicated association between C677T polymorphism and ALL (OR=1.25, 95%CI=0.69-2.23, p=0.552; CT vs. CC).</p><p>Both rs13306561 TC and TC + CC genotype decreased the risk of ALL compared to TT genotype (OR=0.32, 95%CI=0.15-0.68, p=0.002 and OR=0.35, 95%CI=0.17-0.70, p=0.003, respectively). On the other hand, C allele decreased the risk of ALL in comparison with T allele (OR=0.42, 95%CI=0.22-0.78, p=0.005). We also analyzed the MTHFR polymorphisms interaction (<xref ref-type="table" rid="T2">Table 2</xref>). In comparison to the reference MTHFR rs1801131AA/ rs1801133 CC/rs2236242 TT, the AC/CC/TT, AC/CC/TC as well as AA/CC/TC genotypes increased the risk of ALL (OR=3.68, 95%CI=1.26-10.78, p=0.017; OR=4.45, 95%CI=1.11-17.90, p=0.048 and OR=7.71, 95%CI=1.28-46.38, p=0.025, respectively).</p><p>Haplotype analysis results are shown in <xref ref-type="table" rid="T3">Table 3</xref>. The findings showed that ACC haplotypes decreased the risk of ALL compared to CCT haplotypes (rs1801131C/ rs1801133C/ rs13306561T). <xref ref-type="table" rid="T4">Table 4</xref> summarizes the association of MTHFR polymorphisms with patients&#8217; clinical data. The findings proposed an association between rs1801131 variant and hemoglobin (Hb) levels (p=0.033). Rs1801133 variant was not associated with any clinical symptoms in the patient group, while rs13306561 polymorphism was associated with white blood cells (WBC) (p=0.004) and cerebrospinal fluid (CSF) involvement (p=0.004).</p></sec><sec sec-type="discussion"><title>Discussion</title><p> ALL is a multifactorial disease influenced by genetic and environmental factors. In the current study, we examined the impact of MTHFR gene polymorphisms on the risk of childhood ALL in a sample of the Iranian population. Our findings indicated that rs1801131 (A1298C) as well as rs13306561 T&gt;C variants in MTHFR significantly decreased the risk of ALL in our population. While, no significant association between the MTHFR C677T (rs1801133) variant and ALL was found.</p><p>In agreement with our finding a number of previous studies have found no significant association between MTHFR C677T variant and risk of childhood ALL.&#160;<sup><xref rid="B21" ref-type="bibr">21</xref></sup><sup>-</sup><sup><xref rid="B24" ref-type="bibr">24</xref></sup>&#160; Whereas, few groups have reported that MTHFR C677T variant decreased<sup><xref rid="B25" ref-type="bibr">25</xref></sup> or increased the risk of ALL.<sup><xref rid="B12" ref-type="bibr">12</xref></sup> Our results showed the same findings regarding the role of MTHFR A1298C in the decrease of the ALL risk.<sup><xref rid="B12" ref-type="bibr">12</xref></sup> In contrast to our findings, no significant association between MTHFR A1298C polymorphism and ALL has been found.<sup><xref rid="B26" ref-type="bibr">26</xref></sup><sup>-</sup><sup><xref rid="B29" ref-type="bibr">29</xref></sup> Several investigations proposed that MTHFR A1298C polymorphism increased the risk of ALL.<sup><xref rid="B22" ref-type="bibr">22</xref></sup><sup>,</sup><sup><xref rid="B30" ref-type="bibr">30</xref></sup><sup>-</sup><sup><xref rid="B31" ref-type="bibr">31</xref></sup> Recently, a meta-analysis research has been done in a Chinese population and its results suggested that both MTHFR C677T and A1298C polymorphisms may be potential biomarkers for ALL risk.<sup><xref rid="B13" ref-type="bibr">13</xref></sup></p><p>Overall, a significant decreased association was found between the MTHFR C677T polymorphism and ALL risk. In contrast, C677T and A1298C variants were significantly associated with an increased risk of ALL in hospital-based studies, which included individuals with unknown ethnicity.</p><p>Dong et al.<sup><xref rid="B14" ref-type="bibr">14</xref></sup> have done a meta-analysis and showed that MTHFR rs1801131 CC genotype polymorphism significantly increased the risk of myeloid leukemia in Asian populations. In addition, Jiang et al.<sup><xref rid="B25" ref-type="bibr">25</xref></sup> have also indicated that 677TT genotype decreased the risk of ALL in Caucasians in a meta-analysis study (OR=0.715, 95%CI=0.655- 0.781, p=0.000).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Genotypic and allelic frequencies of MTHFR gene polymorphisms in childhood ALL and control subjects</p></caption></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Interaction of MTHFR rs1801131, rs1801133 and rs13306561 polymorphisms on childhood ALL risk</p></caption></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Haplotype frequencies in childhood ALL and control subjects</p></caption></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Association of MTHFR gene polymorphisms with demographic and clinical features of patients</p></caption></table-wrap><p>However, no significant association was found between C677T polymorphism and ALL in Asians and others. In another meta-analysis study, Yan et al.<sup><xref rid="B32" ref-type="bibr">32</xref></sup> have found an overall association between 677T variant genotypes and reduced childhood ALL risk, though they found no significant association between MTHFR A1298C polymorphism and childhood ALL risk.</p><p>In another meta-analysis, it has been showed that the 677T allele was protective, while A1298C was associated with marginal increase in the risk of childhood ALL.<sup><xref rid="B30" ref-type="bibr">30</xref></sup> It has been reported that individuals carrying MTHFR 677T allele may have a higher relative risk of pediatric ALL mortality.<sup><xref rid="B33" ref-type="bibr">33</xref></sup> In a meta-analysis study, no association has been reported between MTHFR A1298C and C677T polymorphisms and pediatric ALL.<sup><xref rid="B29" ref-type="bibr">29</xref></sup> Recently, it has also been shown that the risk of ALL development in children with MTHFR 677 TT genotype decreased in Asian population.<sup><xref rid="B34" ref-type="bibr">34</xref></sup></p><p>Atashrazm et al.<sup><xref rid="B35" ref-type="bibr">35</xref></sup> investigated the impact of MTHFR C677T and A1298C polymorphisms and the risk of ALL in patients referred to the Iranian Blood Transfusion Organization (Tehran, Iran). In agreement with our finding, they found no significant association between MTHFR C677T variant and the risk of childhood ALL. Interestingly, they also found no association between MTHFR A1298C polymorphism and the risk of ALL. It is noteworthy to mention that the genetic background of our population (Baluch and Sistani) was different from their population, which used in their study (patients referred to the Iranian Blood Transfusion Organization, Tehran, Iran who had different genetic background).</p><p>Therefore, it can be concluded that the data regarding the impact of MTHFR on childhood ALL are inconsistent. There is no clear reason for the different results in diverse studies. Ethnic, genetic, and/or environmental factors as well as gene-diet interaction may interact in various ways to either decrease or increase the risk of childhood ALL in different areas.</p><p>Taken together, our findings showed that MTHFR rs1801131 and rs13306561 polymorphisms decreased the risk of ALL in a sample of Iranian population. To further confirm these findings, larger sample sizes with diverse ethnicities are required.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p> The results of the current case-control study showed an association between MTHFR rs1801131 and rs13306561 polymorphisms and risk of ALL in a sample of Iranian population.</p></sec></body><back><ack><title>ACKNOWLEDGEMENT</title><p> This work was supported by a dissertation grant (PhD thesis of GB) from Zahedan University of Medical Sciences.</p></ack><sec><title>CONFLICT OF INTEREST</title><p> All authors declare there is no conflict of interest.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>R</given-names></name><name><surname>Naishadham</surname><given-names>D</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Cancer statistics, 2013</article-title><source> CA Cancer J Clin</source><year>2013</year><volume>63</volume><issue>1</issue><fpage>11</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">23335087</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaatsch</surname><given-names>P</given-names></name></person-group><article-title>Epidemiology of childhood cancer</article-title><source> Cancer Treat Rev</source><year>2010</year><volume>36</volume><issue>4</issue><fpage>277</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">20231056</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>LM</given-names></name><name><surname>Xi</surname><given-names>JS</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><etal/></person-group><article-title>ARID5B gene rs10821936 polymorphism is associated with childhood acute lymphoblastic leukemia: a meta-analysis based on 39,116 subjects</article-title><source> Tumour Biol</source><year>2014</year><volume>35</volume><issue>1</issue><fpage>709</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">23975371</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Sui</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Effect of GSTM1 null genotype on risk of childhood acute leukemia: a meta-analysis</article-title><source> Tumour Biol</source><year>2014</year><volume>35</volume><issue>1</issue><fpage>397</fpage><lpage>402</lpage><pub-id pub-id-type="pmid">24022662</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiemels</surname><given-names>JL</given-names></name><name><surname>Smith</surname><given-names>RN</given-names></name><name><surname>Taylor</surname><given-names>GM</given-names></name><etal/></person-group><article-title>Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia</article-title><source> Proc Natl Acad Sci U S A</source><year>2001</year><volume>98</volume><issue>7</issue><fpage>4004</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11274424</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franco</surname><given-names>RF</given-names></name><name><surname>Simoes</surname><given-names>BP</given-names></name><name><surname>Tone</surname><given-names>LG</given-names></name><etal/></person-group><article-title>The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia</article-title><source> Br J Haematol</source><year>2001</year><volume>115</volume><issue>3</issue><fpage>616</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11736945</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De</surname><given-names>Jonge R</given-names></name><name><surname>Tissing</surname><given-names>WJ</given-names></name><name><surname>Hooijberg</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia</article-title><source> Blood</source><year>2009</year><volume>113</volume><issue>10</issue><fpage>2284</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19020309</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohn</surname><given-names>KJ</given-names></name><name><surname>Jang</surname><given-names>H</given-names></name><name><surname>Campan</surname><given-names>M</given-names></name><etal/></person-group><article-title>The methylenetetrahydrofolate reductase C677T mutation induces cell-specific changes in genomic DNA methylation and uracil misincorporation: a possible molecular basis for the site-specific cancer risk modification</article-title><source> Int J Cancer</source><year>2009</year><volume>124</volume><issue>9</issue><fpage>1999</fpage><lpage>2005</lpage><pub-id pub-id-type="pmid">19123462</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frosst</surname><given-names>P</given-names></name><name><surname>Blom</surname><given-names>HJ</given-names></name><name><surname>Milos</surname><given-names>R</given-names></name><etal/></person-group><article-title>A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase</article-title><source> Nat Genet</source><year>1995</year><volume>10</volume><issue>1</issue><fpage>111</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">7647779</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van</surname><given-names>der Put NM</given-names></name><name><surname>Gabreels</surname><given-names>F</given-names></name><name><surname>Stevens</surname><given-names>EM</given-names></name><etal/></person-group><article-title>A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?</article-title><source> Am J Hum Genet</source><year>1998</year><volume>62</volume><issue>5</issue><fpage>1044</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">9545395</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreile</surname><given-names>M</given-names></name><name><surname>Rots</surname><given-names>D</given-names></name><name><surname>Piekuse</surname><given-names>L</given-names></name><etal/></person-group><article-title>Lack of Association between Polymorphisms in Genes MTHFR and MDR1 with Risk of Childhood Acute Lymphoblastic Leukemia</article-title><source> Asian Pac J Cancer Prev</source><year>2014</year><volume>15</volume><issue>22</issue><fpage>9707</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">25520092</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>RM</given-names></name><name><surname>Fontes</surname><given-names>AC</given-names></name><name><surname>Silva</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Polymorphisms involved in folate metabolism pathways and the risk of the development of childhood acute leukemia</article-title><source> Genet Test Mol Biomarkers</source><year>2013</year><volume>17</volume><issue>2</issue><fpage>147</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">23336575</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Deng</surname><given-names>TR</given-names></name><name><surname>Su</surname><given-names>CL</given-names></name><etal/></person-group><article-title>Methylenetetrahydrofolate reductase polymorphisms and susceptibility to acute lymphoblastic leukemia in a chinese population: a meta-analysis</article-title><source> Oncol Res Treat</source><year>2014</year><volume>37</volume><issue>10</issue><fpage>576</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">25342508</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>MTHFR gene polymorphism and risk of myeloid leukemia: a meta-analysis</article-title><source> Tumour Biol</source><year>2014</year><volume>35</volume><fpage>8913</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">24894669</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashemi</surname><given-names>M</given-names></name><name><surname>Sheybani-Nasab</surname><given-names>M</given-names></name><name><surname>Naderi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Association of functional polymorphism at the miR-502-binding site in the 3' untranslated region of the SETD8 gene with risk of childhood acute lymphoblastic leukemia, a preliminary report</article-title><source> Tumour Biol</source><year>2014</year><volume>35</volume><issue>10</issue><fpage>10375</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">25048968</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasani</surname><given-names>SS</given-names></name><name><surname>Hashemi</surname><given-names>M</given-names></name><name><surname>Eskandari-Nasab</surname><given-names>E</given-names></name><etal/></person-group><article-title>A functional polymorphism in the miR-146a gene is associated with the risk of childhood acute lymphoblastic leukemia: a preliminary report</article-title><source> Tumour Biol</source><year>2014</year><volume>35</volume><issue>1</issue><fpage>219</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">23888320</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashemi</surname><given-names>M</given-names></name><name><surname>Ebrahimi</surname><given-names>M</given-names></name><name><surname>Amininia</surname><given-names>S</given-names></name><etal/></person-group><article-title>Evaluation of rs3102735 and rs2073617 Osteoprotegerin Gene Polymorphisms and the Risk of Childhood Acute lymphoblastic Leukemia in Zahedan Southeast Iran</article-title><source> Int J Hematol Oncol Stem Cell Res</source><year>2014</year><volume>8</volume><issue>4</issue><fpage>39</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">25774266</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahari</surname><given-names>G</given-names></name><name><surname>Hashemi</surname><given-names>M</given-names></name><name><surname>Naderi</surname><given-names>M</given-names></name><etal/></person-group><article-title>IKZF1 gene polymorphisms increased the risk of childhood acute lymphoblastic leukemia in an Iranian population</article-title><source> Tumour Biol</source><year>2016</year><comment>DOI: 10.1007/s13277-016-4853-0</comment></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashemi</surname><given-names>M</given-names></name><name><surname>Hanafi</surname><given-names>Bojd H</given-names></name><name><surname>Eskandari</surname><given-names>Nasab E</given-names></name><etal/></person-group><article-title>Association of Adiponectin rs1501299 and rs266729 Gene Polymorphisms With Nonalcoholic Fatty Liver Disease</article-title><source> Hepat Mon</source><year>2013</year><volume>13</volume><issue>5</issue><fpage>e9527</fpage><pub-id pub-id-type="pmid">23922565</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sole</surname><given-names>X</given-names></name><name><surname>Guino</surname><given-names>E</given-names></name><name><surname>Valls</surname><given-names>J</given-names></name><etal/></person-group><article-title>SNPStats: a web tool for the analysis of association studies</article-title><source> Bioinformatics</source><year>2006</year><volume>22</volume><issue>15</issue><fpage>1928</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16720584</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balta</surname><given-names>G</given-names></name><name><surname>Yuksek</surname><given-names>N</given-names></name><name><surname>Ozyurek</surname><given-names>E</given-names></name><etal/></person-group><article-title>Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia</article-title><source> Am J Hematol</source><year>2003</year><volume>73</volume><issue>3</issue><fpage>154</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">12827651</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Liao</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Association of methylenetetrahytrofolate reductase (MTHFR) C677T and A1298C polymorphisms with the susceptibility of childhood acute lymphoblastic leukaemia (ALL) in Chinese population</article-title><source> Eur J Med Res</source><year>2014</year><volume>19</volume><fpage>5</fpage><pub-id pub-id-type="pmid">24476575</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azhar</surname><given-names>MR</given-names></name><name><surname>Rahimi</surname><given-names>Z</given-names></name><name><surname>Vaisi-Raygani</surname><given-names>A</given-names></name><etal/></person-group><article-title>Lack of association between MTHFR C677T and A1298C polymorphisms and risk of childhood acute lymphoblastic leukemia in the Kurdish population from Western Iran</article-title><source> Genet Test Mol Biomarkers</source><year>2012</year><volume>16</volume><issue>3</issue><fpage>198</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">22017305</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>N</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>The relationship between methylenetetrahydrofolate reductase polymorphism and hematological malignancy</article-title><source> Clin Lab</source><year>2014</year><volume>60</volume><issue>5</issue><fpage>767</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">24839819</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Hou</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>The MTHFR C677T polymorphism and risk of acute lymphoblastic leukemia: an updated meta-analysis based on 37 case-control studies</article-title><source> Asian Pac J Cancer Prev</source><year>2013</year><volume>14</volume><issue>11</issue><fpage>6357</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">24377532</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellampalli</surname><given-names>R</given-names></name><name><surname>Phani</surname><given-names>NM</given-names></name><name><surname>Bhat</surname><given-names>KG</given-names></name><etal/></person-group><article-title>Significance of 5,10-methylenetetrahydrofolate reductase gene variants in acute lymphoblastic leukemia in Indian population: an experimental, computational and meta-analysis</article-title><source> Leuk Lymphoma</source><year>2015</year><volume>56</volume><issue>5</issue><fpage>1450</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">25115513</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sazawal</surname><given-names>S</given-names></name><name><surname>Chaubey</surname><given-names>R</given-names></name><name><surname>Kaur</surname><given-names>P</given-names></name><etal/></person-group><article-title>MTHFR Gene Polymorphisms and the Risk of Acute Lymphoblastic Leukemia in Adults and Children: A Case Control Study in India</article-title><source> Indian J Hematol Blood Transfus</source><year>2014</year><volume>30</volume><issue>4</issue><fpage>219</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">25435717</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnakenberg</surname><given-names>E</given-names></name><name><surname>Mehles</surname><given-names>A</given-names></name><name><surname>Cario</surname><given-names>G</given-names></name><etal/></person-group><article-title>Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population</article-title><source> BMC Med Genet</source><year>2005</year><volume>6</volume><fpage>23</fpage><pub-id pub-id-type="pmid">15921520</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zintzaras</surname><given-names>E</given-names></name><name><surname>Doxani</surname><given-names>C</given-names></name><name><surname>Rodopoulou</surname><given-names>P</given-names></name><etal/></person-group><article-title>Variants of the MTHFR gene and susceptibility to acute lymphoblastic leukemia in children: a synthesis of genetic association studies</article-title><source> Cancer Epidemiol</source><year>2012</year><volume>36</volume><issue>2</issue><fpage>169</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">22094326</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>Moulik N</given-names></name><name><surname>Parveen</surname><given-names>F</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><etal/></person-group><article-title>MTHFR gene polymorphism in acute lymphoblastic leukemia among North Indian children: a case-control study and meta-analysis updated from 2011</article-title><source> J Hum Genet</source><year>2014</year><volume>59</volume><issue>7</issue><fpage>397</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">24919644</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>NK</given-names></name><name><surname>Chong</surname><given-names>SY</given-names></name><name><surname>Jang</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Association of the methylenetetrahydrofolate reductase polymorphism in Korean patients with childhood acute lymphoblastic leukemia</article-title><source> Anticancer Res</source><year>2006</year><volume>26</volume><issue>4B</issue><fpage>2879</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">16886608</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Yin</surname><given-names>M</given-names></name><name><surname>Dreyer</surname><given-names>ZE</given-names></name><etal/></person-group><article-title>A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children</article-title><source> Pediatr Blood Cancer</source><year>2012</year><volume>58</volume><issue>4</issue><fpage>513</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">21495160</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojha</surname><given-names>RP</given-names></name><name><surname>Gurney</surname><given-names>JG</given-names></name></person-group><article-title>Methylenetetrahydrofolate reductase C677T and overall survival in pediatric acute lymphoblastic leukemia: a systematic review</article-title><source> Leuk Lymphoma</source><year>2014</year><volume>55</volume><issue>1</issue><fpage>67</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">23550988</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Zeng</surname><given-names>X</given-names></name></person-group><article-title>The association between methylenetetrahydrofolate reductase C677 &gt; T polymorphisms and risk of pediatric acute lymphoblastic leukemia in Asia</article-title><source> J Cancer Res Ther</source><year>2014</year><volume>10 </volume><issue>Suppl</issue><fpage>C210</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">25450284</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atashrazm</surname><given-names>F</given-names></name><name><surname>Zaker</surname><given-names>F</given-names></name><name><surname>Aghaeipour</surname><given-names>M</given-names></name><etal/></person-group><article-title>Polymorphisms of the methylene tetrahydrofolate reductase and susceptibility to acute lymphoblastic leukemia in children</article-title><source> Lab Med</source><year>2011</year><volume>42</volume><issue>5</issue><fpage>275</fpage><lpage>79</lpage></element-citation></ref></ref-list></back></article>